LambdaVision to Study Light-Activated Proteins on NASA’s Upcoming Flight to International Space Station

FARMINGTON, Conn. (LambdaVision PR) — LambdaVision, an innovative biotech developing a treatment to help patients regain sight, will launch their artificial retina technology with engineering partner Space Tango on Northrop Grumman’s 14th Commercial Resupply Services Mission for NASA (NG-14) to the International Space Station (ISS) U.S. National Laboratory.

Scheduled to launch on September 30th at 2:26 UTC (10:26 p.m. ET), NG-14 is the first of a series of NASA flights to the ISS in low-Earth orbit (LEO) focused on developing the on-orbit production of LambdaVision’s artificial retina.

(more…)

Cygnus to Carry Multiple R&D Payloads Sponsored by the ISS National Lab

KENNEDY SPACE CENTER (FL), January 30, 2020 (ISS National Lab) – Northrop Grumman’s Cygnus spacecraft will be packed with a wide variety of research investigations for its 13th commercial resupply services mission (contracted by NASA) to the International Space Station (ISS). The launch—which is slated for no earlier than Sunday, February 9 at 5:39 p.m. EST from NASA’s Wallops Flight Facility in Virginia—will carry a diverse set of research and technology development projects sponsored by the U.S. National Laboratory. This launch represents the first commercial resupply services mission to the ISS in 2020.

(more…)

miniPCR Announces First DNA Amplification in Space

Thermal cycler (Credit: miniPCR)
Thermal cycler (Credit: miniPCR)

CAMBRIDGE, Mass., May 25, 2016 (miniPCR PR) — miniPCR™ announced the first successful DNA amplification on the International Space Station (ISS). Using a miniPCR thermal cycler, astronauts performed Polymerase Chain Reaction (PCR) on DNA samples on April 19th. Analysis performed today on Earth confirms that DNA amplification done in microgravity was successful, ushering in a new era in space exploration.

(more…)